Berliner Boersenzeitung - US panel weighs authorizing Covid vaccines for youngest children

EUR -
AED 4.315061
AFN 77.724052
ALL 96.430624
AMD 448.409899
ANG 2.103659
AOA 1077.442142
ARS 1689.86317
AUD 1.771311
AWG 2.117872
AZN 2.000409
BAM 1.955407
BBD 2.365825
BDT 143.551156
BGN 1.955723
BHD 0.442954
BIF 3469.888012
BMD 1.174964
BND 1.514389
BOB 8.146363
BRL 6.363838
BSD 1.174664
BTN 106.549193
BWP 15.513883
BYN 3.43521
BYR 23029.292606
BZD 2.362425
CAD 1.618037
CDF 2643.668428
CHF 0.935862
CLF 0.027385
CLP 1074.304613
CNY 8.280264
CNH 8.270365
COP 4486.012203
CRC 587.581934
CUC 1.174964
CUP 31.136544
CVE 110.242848
CZK 24.334798
DJF 209.177969
DKK 7.469862
DOP 74.615007
DZD 152.355249
EGP 55.786091
ERN 17.624459
ETB 182.824164
FJD 2.707411
FKP 0.878162
GBP 0.87939
GEL 3.166584
GGP 0.878162
GHS 13.508286
GIP 0.878162
GMD 86.356626
GNF 10214.903998
GTQ 8.998192
GYD 245.75062
HKD 9.139045
HNL 30.940783
HRK 7.533746
HTG 153.908419
HUF 384.767195
IDR 19613.555028
ILS 3.788072
IMP 0.878162
INR 107.0163
IQD 1538.79735
IRR 49477.729809
ISK 148.209797
JEP 0.878162
JMD 187.72228
JOD 0.83304
JPY 181.945504
KES 151.570389
KGS 102.7508
KHR 4700.035597
KMF 493.48453
KPW 1057.467812
KRW 1734.02351
KWD 0.360476
KYD 0.978907
KZT 605.860839
LAK 25453.88542
LBP 105208.716305
LKR 363.207019
LRD 207.354807
LSL 19.70844
LTL 3.469363
LVL 0.710724
LYD 6.367721
MAD 10.782034
MDL 19.828016
MGA 5235.947914
MKD 61.529756
MMK 2467.149311
MNT 4167.41132
MOP 9.416348
MRU 46.726611
MUR 53.953914
MVR 18.090249
MWK 2036.890717
MXN 21.142242
MYR 4.799753
MZN 75.091164
NAD 19.708524
NGN 1706.364458
NIO 43.231129
NOK 11.939308
NPR 170.456749
NZD 2.033351
OMR 0.451772
PAB 1.174664
PEN 3.955622
PGK 4.991976
PHP 69.151912
PKR 329.196053
PLN 4.220693
PYG 7889.414739
QAR 4.28114
RON 5.092412
RSD 117.375408
RUB 93.410413
RWF 1710.256349
SAR 4.408683
SBD 9.587758
SCR 16.622882
SDG 706.738724
SEK 10.924779
SGD 1.517208
SHP 0.881527
SLE 28.257383
SLL 24638.409984
SOS 670.16534
SRD 45.365159
STD 24319.380662
STN 24.494974
SVC 10.277979
SYP 12993.304299
SZL 19.712039
THB 37.042495
TJS 10.802308
TMT 4.112374
TND 3.43531
TOP 2.829032
TRY 50.181881
TTD 7.972398
TWD 36.98804
TZS 2919.78564
UAH 49.650723
UGX 4184.159255
USD 1.174964
UYU 46.036627
UZS 14211.204945
VES 314.232054
VND 30939.73712
VUV 142.713252
WST 3.265592
XAF 655.825222
XAG 0.018677
XAU 0.000274
XCD 3.175399
XCG 2.116984
XDR 0.815636
XOF 655.825222
XPF 119.331742
YER 280.170076
ZAR 19.761072
ZMK 10576.086666
ZMW 27.22253
ZWL 378.337899
  • SCS

    0.0200

    16.14

    +0.12%

  • CMSD

    0.1150

    23.365

    +0.49%

  • BTI

    0.6400

    57.74

    +1.11%

  • NGG

    1.1000

    76.03

    +1.45%

  • RIO

    0.1600

    75.82

    +0.21%

  • GSK

    0.4300

    49.24

    +0.87%

  • BP

    -0.0100

    35.25

    -0.03%

  • BCC

    -1.1800

    75.33

    -1.57%

  • CMSC

    0.0000

    23.3

    0%

  • RBGPF

    0.4300

    81.6

    +0.53%

  • BCE

    0.2161

    23.61

    +0.92%

  • RYCEF

    0.3100

    14.95

    +2.07%

  • VOD

    0.1100

    12.7

    +0.87%

  • JRI

    -0.0065

    13.56

    -0.05%

  • RELX

    0.7000

    41.08

    +1.7%

  • AZN

    1.7300

    91.56

    +1.89%

US panel weighs authorizing Covid vaccines for youngest children
US panel weighs authorizing Covid vaccines for youngest children / Photo: Frederic J. BROWN - AFP/File

US panel weighs authorizing Covid vaccines for youngest children

After months of anxious wait for some parents, a panel of experts convened by the US Food and Drug Administration will meet Wednesday to weigh recommending Covid vaccines for the nation's youngest children.

Text size:

Children under five are the only age group not yet eligible for Covid immunization in the United States and most other countries. If, as expected, panelists vote in favor of greenlighting the Pfizer and Moderna vaccines, formal authorizations should follow quickly, with the first shots in arms expected by next week.

Ahead of the meeting, the FDA posted its independent analyses of the two drugs, deeming both safe and effective. It also said there was a pressing unmet need to inoculate children in the age group since their rates of hospitalization and death "are higher than among children and adolescents 5-17 years of age."

Both vaccines are based on messenger RNA technology, which delivers genetic code for the coronavirus spike protein to human cells, training the immune system to be ready for when it encounters the real virus.

Pfizer is seeking authorization for three doses at three micrograms given to ages six months through four years, while Moderna has asked for the FDA to approve its vaccine as two doses of a higher 30 micrograms, for ages six months through five years.

They were tested in trials of thousands of children where they were found to have similar levels of mild effects to older age groups and triggered similar levels of antibodies.

Efficacy against infection was higher for Pfizer, with the company placing it at 80 percent compared to Moderna's estimates of 51 percent in the six-month-old to age two group and 37 percent in the two to five years age group.

But the figures are provisional and Moderna is studying adding a third dose later that may increase its figures.

There are some 20 million US children aged four years and under. If the FDA-appointed experts recommend the two vaccines, then the matter will go to another committee convened by the Centers for Disease Control and Prevention for a final say.

White House officials last week said the rollout of millions of shots at pharmacies and doctors' offices could begin as soon as June 21, following the Juneteenth holiday on June 20.

Of the total US Covid deaths, 480 have come in children under five, according to the latest official data.

Obesity, neurological disorders and asthma are associated with increased risk of severe disease, "however, a majority of children hospitalized for Covid-19 have no underlying medical conditions," the FDA said in a document.

Children can also go on to contract multisystem inflammatory syndrome in children (MIS-C), a rare but serious post-viral condition.

Data on long Covid in children is sparse, but the FDA's document cited a national survey in the United Kingdom which found that "among children ages two to 11 years who tested positive for COVID-19, 7.2 percent reported continued symptoms at 12 weeks."

(S.G.Stein--BBZ)